Precision medicine is transforming the pharmaceutical landscape, delivering highly targeted therapies that drive significant improvements in patient outcomes. However, without a robust companion diagnostics (CDx) strategy, even the most innovative treatments risk falling short of their commercial and clinical potential.
Watch our webinar recording to explore the critical steps for driving biomarker testing adoption, from building physician awareness to enabling informed treatment decisions. Drawing on real-world examples and industry benchmarks, we will identify common bottlenecks, explain why they matter, and share practical solutions to address them proactively.
This recording covers:
- The six critical points along the patient journey where barriers to testing can derail drug adoption and how to overcome them
- Proven best practices to increase the availability and uptake of CDx
- Key initiatives to include in a robust commercial CDx strategy and when to launch them for maximum impact
